Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) Short Interest Update theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Lipella Pharmaceuticals’ (NASDAQ:LIPO – Get Rating) lock-up period will expire on Monday, June 19th. Lipella Pharmaceuticals had issued 1,217,391 shares in its IPO on December 20th. The total size of the offering was $6,999,998 based on an initial share price of $5.75. Shares of the company owned by company insiders and major shareholders will be […]
Lipella Pharmaceuticals’ (NASDAQ:LIPO – Get Rating) lock-up period will expire on Monday, June 19th. Lipella Pharmaceuticals had issued 1,217,391 shares in its public offering on December 20th. The total size of the offering was $6,999,998 based on an initial share price of $5.75. After the expiration of Lipella Pharmaceuticals’ lock-up period, restrictions preventing company insiders […]
Lipella Pharmaceuticals (NASDAQ:LIPO – Get Rating) and Veru (NASDAQ:VERU – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Profitability This table compares Lipella Pharmaceuticals and Veru’s net margins, […]